Skip to main content
Clinical Trials/NCT05978921
NCT05978921Not yet recruitingNot Applicable

Effect of Physical Strength Exercise on Telomeric Length as a Marker of Aging and Early Death in Patients With Schizophrenia

University of Salamanca2 sites in 1 country40 target enrollmentStarted: March 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
40
Locations
2
Primary Endpoint
Telomere Length

Study Overview

Brief Summary

Randomised clinical trial on a cohort of subjects with a diagnosis of schizophrenia of legal age, of both sexes, recruited in the mental health clinics of the Salamanca University Assistance Complex and who will be randomly distributed into two groups (intervention and control).

The main objective of the study is to determine the effect of physical exercise on telomere size in patients diagnosed with schizophrenia.

As secondary objectives in this group of patients we will try to:

Evaluate the influence of strength training on cognition and negative symptoms of schizophrenia.

To quantify the impact of strength training on frailty. To determine the effect of strength training on quality of life. To study the possible correlation between physical parameters (frailty) and telomere length.

To establish the importance of polymorphisms in telomerase genes, an enzyme involved in the maintenance of telomere length.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Single (Outcomes Assessor)

Masking Description

The persons in charge of the evaluation of the participants will be unaware of the assignment of the participants.

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • be at least 18 years of age
  • have been diagnosed with schizophrenia for at least 5 years

Exclusion Criteria

  • are unable to read and understand the patient information sheet and sign the informed consent form.

Outcomes

Primary Outcomes

Telomere Length

Time Frame: Baseline and immediately after the intervention

Telomere length will be measured before and after the procedure in kilobases.

Secondary Outcomes

  • Cognition(Baseline and immediately after the intervention)
  • Sex(Baseline)
  • Fragility(Baseline and immediately after the intervention)
  • Date of birth(Baseline)
  • Quality of life(Baseline and immediately after the intervention)
  • Heighth(Baseline)
  • Negative Symptoms(Baseline and immediately after the intervention)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Juan Luis Sanchez Gonzalez

Principal Investigator. Juan Luis Sánchez González

University of Salamanca

Study Sites (2)

Loading locations...

Similar Trials